QOF Cholesterol Control and Lipid Management guidance

‘Cholesterol Control and Lipid Management’ was introduced to QOF this year, designed to support high-risk CVD patients who could benefit from further combination therapies. 

Practices should be aware: At the point data is collected to assess QOF achievement, patients will need to have a prescription for a statin/lipid lowering therapy on their records (CHOL001) and have a non-HDLC or LDLC reading at or below targets within the 12-month QOF Period (CHOL002). UK guidance indicates a 12-week wait from initiation of therapy to re-testing of lipids, so practices will need to have initiated the above activity by 31 December 2023 to get the appropriate follow-up test results in the system in time for the QOF data collection.

Please download the Steps to take now to maximise your achievement